Lin-Quan Tang Selected Research

Lin-Quan Tang Research Topics

Disease

109	Nasopharyngeal Carcinoma 01/2024 - 01/2013
32	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2013
21	Neoplasms (Cancer) 11/2023 - 01/2013
3	Necrosis 11/2023 - 01/2019
3	Mucositis 01/2023 - 08/2017
2	Leukopenia 01/2023 - 12/2018
2	Neutropenia 01/2023 - 12/2018
2	Hearing Loss (Hearing Impairment) 01/2023 - 01/2020
2	Disease Progression 12/2021 - 11/2015
2	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2018
2	Anemia 10/2021 - 01/2015
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 01/2021
2	Xerostomia 01/2020 - 01/2013
2	Venous Thromboembolism 12/2018 - 01/2018
1	Radiation Injuries (Radiation Sickness) 11/2023
1	Tertiary Lymphoid Structures 01/2023
1	Infections 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Body Weight (Weight, Body) 09/2021
1	Squamous Cell Carcinoma of Head and Neck 05/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Dermatitis 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Trismus (Lockjaw) 01/2020
1	Circulating Neoplastic Cells 11/2019
1	Stomatitis 10/2019
1	Pain (Aches) 10/2019
1	Lymphadenopathy 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 11/2018
1	Vomiting 01/2018
1	Ototoxicity 01/2018
1	Anorexia 01/2018
1	Nausea 01/2018
1	Exanthema (Rash) 08/2017

Drug/Important Bio-Agent (IBA)

41	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2013
18	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2013
6	Capecitabine (Xeloda)FDA Link 01/2024 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
4	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 12/2018
4	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 01/2022 - 01/2016
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 08/2013
3	Docetaxel (Taxotere)FDA Link 12/2023 - 12/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 12/2018
3	Viral DNAIBA 01/2019 - 11/2015
2	AlbuminsIBA 01/2023 - 09/2021
2	apatinibIBA 01/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2019
2	Gemcitabine FDA Link 01/2023 - 01/2020
2	LigandsIBA 01/2023 - 01/2020
2	PlatinumIBA 01/2023 - 01/2023
2	ChemokinesIBA 01/2023 - 01/2020
2	nedaplatinIBA 12/2021 - 01/2018
2	EnzymesIBA 10/2021 - 03/2016
2	Hemoglobins (Hemoglobin)IBA 09/2021 - 01/2015
2	Cetuximab (Erbitux)FDA Link 01/2019 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 09/2015
2	C-Reactive ProteinIBA 07/2018 - 02/2015
2	AntibodiesIBA 03/2016 - 01/2016
2	AntigensIBA 03/2016 - 01/2016
2	Immunoglobulin A (IgA)IBA 03/2016 - 01/2016
2	Complement System Proteins (Complement)IBA 03/2016 - 02/2016
2	Glycoproteins (Glycoprotein)IBA 03/2016 - 01/2016
1	toripalimabIBA 01/2024
1	Albumin-Bound Paclitaxel FDA Link 12/2023
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	Liposomes (Liposome)IBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	camrelizumabIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	angiogeninIBA 01/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2019
1	nimotuzumabIBA 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	AnticoagulantsIBA 12/2018
1	Taxoids (Taxanes)IBA 12/2018
1	ForminsIBA 11/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2018

Therapy/Procedure

34	Chemoradiotherapy 12/2023 - 01/2013
32	Radiotherapy 11/2023 - 11/2014
20	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
19	Induction Chemotherapy 12/2023 - 11/2014
17	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023 - 01/2013
13	Therapeutics 01/2024 - 01/2013
4	Neoadjuvant Therapy 01/2019 - 11/2015
3	Immunotherapy 01/2023 - 02/2015
3	Neck Dissection (Radical Neck Dissection) 11/2022 - 01/2018
2	Adjuvant Chemotherapy 12/2021 - 01/2019
2	Re-Irradiation 01/2020 - 10/2016
2	Catheters 12/2018 - 01/2018
1	TP protocol 01/2022
1	Maintenance Chemotherapy 11/2021
1	Salvage Therapy 01/2020
1	Aftercare (After-Treatment) 10/2019